Citigroup’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.4M Buy
249,243
+147,142
+144% +$9.35M 0.01% 1180
2025
Q4
$6.49M Buy
102,101
+37,203
+57% +$2.31M ﹤0.01% 1833
2025
Q3
$3.57M Sell
64,898
-79,939
-55% -$3.29M ﹤0.01% 2215
2025
Q2
$4.79M Sell
144,837
-160,758
-53% -$5.59M ﹤0.01% 1927
2025
Q1
$12.3M Buy
305,595
+10,465
+4% +$481K 0.01% 1244
2024
Q4
$13.9M Buy
295,130
+105,285
+55% +$5.47M 0.01% 1176
2024
Q3
$10M Buy
189,845
+58,491
+45% +$3.26M 0.01% 1340
2024
Q2
$7.12M Sell
131,354
-32,845
-20% -$1.98M 0.01% 1431
2024
Q1
$11.5M Buy
164,199
+5,225
+3% +$404K 0.01% 1173
2023
Q4
$13.3M Buy
158,974
+16,260
+11% +$589K 0.02% 1066
2023
Q3
$4.2M Sell
142,714
-32,789
-19% -$1.09M 0.01% 1533
2023
Q2
$5.72M Sell
175,503
-50,356
-22% -$1.86M 0.01% 1413
2023
Q1
$7.95M Buy
225,859
+69,332
+44% +$2.83M 0.01% 1266
2022
Q4
$7.17M Sell
156,527
-3,661
-2% -$158K 0.01% 1297
2022
Q3
$7.76M Buy
160,188
+24,108
+18% +$1.16M 0.01% 1279
2022
Q2
$5.35M Buy
136,080
+40,400
+42% +$1.63M 0.01% 1501
2022
Q1
$3.52M Sell
95,680
-77,979
-45% -$2.77M ﹤0.01% 1899
2021
Q4
$7.92M Buy
173,659
+60,249
+53% +$2.32M 0.01% 1532
2021
Q3
$4.05M Sell
113,410
-128,425
-53% -$3.78M ﹤0.01% 1957
2021
Q2
$4.79M Buy
241,835
+55,089
+29% +$1.29M ﹤0.01% 1929
2021
Q1
$4.34M Buy
186,746
+164,502
+740% +$3.51M ﹤0.01% 1881
2020
Q4
$462K Buy
22,244
+13,415
+152% +$245K ﹤0.01% 4274
2020
Q3
$191K Sell
8,829
-40,714
-82% -$952K ﹤0.01% 4648
2020
Q2
$1.17M Buy
49,543
+7,941
+19% +$149K ﹤0.01% 3392
2020
Q1
$490K Sell
41,602
-2,133
-5% -$27.2K ﹤0.01% 3892
2019
Q4
$464K Sell
43,735
-57,750
-57% -$593K ﹤0.01% 4479
2019
Q3
$1.16M Buy
101,485
+21,993
+28% +$276K ﹤0.01% 3485
2019
Q2
$894K Buy
79,492
+47,114
+146% +$454K ﹤0.01% 3765
2019
Q1
$262K Sell
32,378
-99,616
-75% -$732K ﹤0.01% 4836
2018
Q4
$834K Buy
131,994
+100,664
+321% +$738K ﹤0.01% 3578
2018
Q3
$309K Sell
31,330
-91
-0.3% -$730 ﹤0.01% 4803
2018
Q2
$261K Sell
31,421
-740,900
-96% -$6.17M ﹤0.01% 4784
2018
Q1
$5.56M Sell
772,321
-46,707
-6% -$400K 0.01% 1673
2017
Q4
$6.67M Buy
819,028
+30,321
+4% +$344K 0.01% 1578
2017
Q3
$11.4M Sell
788,707
-11,764
-1% -$161K 0.02% 1143
2017
Q2
$9.69M Buy
800,471
+71,811
+10% +$998K 0.02% 1168
2017
Q1
$9.36M Sell
728,660
-21,099
-3% -$247K 0.02% 1179
2016
Q4
$9.11M Buy
749,759
+41,721
+6% +$443K 0.02% 1266
2016
Q3
$6.5M Sell
708,038
-3,781
-0.5% -$39.5K 0.01% 1432
2016
Q2
$6.75M Sell
711,819
-33,581
-5% -$276K 0.02% 1306
2016
Q1
$5.25M Buy
745,400
+22,824
+3% +$167K 0.01% 1509
2015
Q4
$7.56M Buy
722,576
+93,319
+15% +$915K 0.02% 1366
2015
Q3
$4.21M Buy
629,257
+619,298
+6,218% +$4.23M 0.01% 1809
2015
Q2
$67K Buy
9,959
+6,556
+193% +$43K ﹤0.01% 5302
2015
Q1
$23K Sell
3,403
-5,543
-62% -$41.4K ﹤0.01% 6017
2014
Q4
$72K Buy
8,946
+4,505
+101% +$19.3K ﹤0.01% 5453
2014
Q3
$16K Buy
4,441
+3,221
+264% +$13.5K ﹤0.01% 6020
2014
Q2
$6K Sell
1,220
-6,140
-83% -$37.5K ﹤0.01% 6370
2014
Q1
$70K Sell
7,360
-2,431
-25% -$22K ﹤0.01% 5265
2013
Q4
$63K Buy
9,791
+7,207
+279% +$47.3K ﹤0.01% 5586
2013
Q3
$20K Sell
2,584
-16,387
-86% -$176K ﹤0.01% 5908
2013
Q2
$219K Buy
+18,971
New +$149K ﹤0.01% 4200

Other funds holding CYTK